View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
 PRESS RELEASE

Bitcoin Depot Announces Strategic Investment from Sopris Capital

Bitcoin Depot Announces Strategic Investment from Sopris Capital ATLANTA, April 25, 2024 (GLOBE NEWSWIRE) -- (“Bitcoin Depot” or the “Company”) (NASDAQ: BTM), a U.S.-based Bitcoin ATM (“BTM”) operator and leading fintech company, today announced a strategic investment from (“Sopris”), a 20-year-old multi-strategy investment firm. As part of the investment, Sopris Capital has purchased 2,906,976 Class A common shares and is now one of the Company`s largest independent shareholders. “We are thrilled to own part of a growing, market-leading business at such a compelling valuation. We look ...

 PRESS RELEASE

EQS-News: SHS VIVEON AG erzielt EUR 8,85 Mio. Konzernumsatz im Geschäf...

EQS-News: SHS VIVEON AG / Schlagwort(e): Jahresbericht SHS VIVEON AG erzielt EUR 8,85 Mio. Konzernumsatz im Geschäftsjahr 2023 25.04.2024 / 14:00 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. SHS VIVEON AG erzielt EUR 8,85 Mio. Konzernumsatz im Geschäftsjahr 2023 München, 25. April 2024 – Die SHS Viveon AG („SHS Viveon“); (DE000A0XFWK2) hat am 25. April 2024 die Ergebnisse für das Geschäftsjahr 2023 veröffentlicht. Demnach erzielte das Unternehmen 2023 einen Konzernumsatz in Höhe von EUR 8,85 Mio. nach EUR 9,12 Mio. im Vorjahr. Im ...

 PRESS RELEASE

Standard BioTools Announces Operational Restructuring Plan to Drive Lo...

Standard BioTools Announces Operational Restructuring Plan to Drive Long-Term Profitable Growth Company expects to achieve $45-$50 million in annualized operating expense savings in fiscal 2025Management to discuss first quarter 2024 financial results, restructuring and strategic initiatives on May 8, 2024 conference call SOUTH SAN FRANCISCO, Calif., April 25, 2024 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (“Standard BioTools” or the “Company”) (Nasdaq: LAB) today announced that it has initiated a restructuring plan to improve operational efficiency and reduce operating costs, while sup...

 PRESS RELEASE

Lakeland Financial Reports First Quarter Net Income of $23.4 Million a...

Lakeland Financial Reports First Quarter Net Income of $23.4 Million and 5% Annualized Average Loan Growth WARSAW, Ind., April 25, 2024 (GLOBE NEWSWIRE) -- Lakeland Financial Corporation (Nasdaq Global Select/LKFN), parent company of Lake City Bank, today reported net income of $23.4 million for the three months ended March 31, 2024, which represents a decrease of $877,000, or 4%, compared with net income of $24.3 million for the three months ended March 31, 2023. Diluted earnings per share were $0.91 for the first quarter of 2024 and decreased 3% compared to $0.94 for the first quarter o...

 PRESS RELEASE

First Merchants Corporation Announces First Quarter 2024 Earnings Per ...

First Merchants Corporation Announces First Quarter 2024 Earnings Per Share MUNCIE, Ind., April 25, 2024 (GLOBE NEWSWIRE) -- First Merchants Corporation (NASDAQ - FRME) First Quarter 2024 Highlights: Net income available to common stockholders was $47.5 million and diluted earnings per common share totaled $0.80 compared to $63.6 million and $1.07 in the first quarter of 2023, and $42.0 million and $0.71 in the fourth quarter of 2023.   Net income and diluted earnings per common share, excluding non-core charges of $3.5 million incurred during the quarter, totaled $50.1 million and $0.8...

Topicus.com Inc: 1 director

A director at Topicus.com Inc bought 59,779,702 shares at 124.041CAD and the significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years...

Sterling & Wilson Renewable Energy Ltd: 1 director

A director at Sterling & Wilson Renewable Energy Ltd sold 14,500 shares at 638.131INR and the significance rating of the trade was 72/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over th...

Lifco AB: 2 directors

A director at Lifco AB bought 2,000 shares at 262.640SEK and the significance rating of the trade was 37/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly show...

 PRESS RELEASE

Assertio Holdings, Inc. to Report First Quarter 2024 Financial Results...

Assertio Holdings, Inc. to Report First Quarter 2024 Financial Results on May 6, 2024 LAKE FOREST, Ill., April 25, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities offering differentiated products to patients, today announced that it will release first quarter 2024 financial results on Monday, May 6, 2024, after the market close. Following the release of its financial results, Assertio’s management will host a live webcast of the earnings conference call at 4:30 p.m. Eastern T...

 PRESS RELEASE

ProPhase Labs to Present at the Planet MicroCap Showcase: VEGAS 2024 o...

ProPhase Labs to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 & 1x1 Meetings on Thursday, May 2, 2024 Garden City, NY, April 25, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a biopharma, genomics and diagnostics Company, today announced that it will be presenting at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 at 11:30 am PST, 2:30 pm EST. Ted Karkus, CEO, will be hosting the presentation and answering questions at the conclusion. To access the live presentation, please use the following information: Planet Micro...

 PRESS RELEASE

Collegium to Report First Quarter 2024 Financial Results on May 9, 202...

Collegium to Report First Quarter 2024 Financial Results on May 9, 2024 STOUGHTON, Mass., April 25, 2024 (GLOBE NEWSWIRE) --  (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions, today announced that it will report first quarter 2024 financial results after the market closes on Thursday, May 9, 2024. Following the release of the financials, the Company will host a live conference call and webcast at 4:30 p.m. ET. Conference Call Information To access the conference call, please dial (877...

 PRESS RELEASE

Achieve Life Sciences to Announce First Quarter Financial Results and ...

Achieve Life Sciences to Announce First Quarter Financial Results and Host Conference Call and Webcast on May 9, 2024 SEATTLE and VANCOUVER, British Columbia, April 25, 2024 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine dependence, today announced it will report its first quarter 2024 financial results and provide an update on the cytisinicline development program on Thursday, May 9, 2024, at 4:30 PM EDT. To access the webcast...

 PRESS RELEASE

iSpecimen to Report First Quarter 2024 Financial Results on May 7, 202...

iSpecimen to Report First Quarter 2024 Financial Results on May 7, 2024 LEXINGTON, Mass., April 25, 2024 (GLOBE NEWSWIRE) --  (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, today announced that it will report its financial results for the first quarter of 2024 ended March 31, 2024 before the market opens on Tuesday, May 7, 2024. The Company will host a conference call and audio webcast that morning at 8:30 a.m. Eastern Time featuring remarks b...

 PRESS RELEASE

Genasys Inc. Schedules Fiscal Second Quarter 2024 Financial Results an...

Genasys Inc. Schedules Fiscal Second Quarter 2024 Financial Results and Conference Call for May 14, 2024 SAN DIEGO, April 25, 2024 (GLOBE NEWSWIRE) -- Genasys Inc. (NASDAQ: GNSS), the global leader in protective communications, today announced plans to release financial results for its fiscal second quarter, ended March 31, 2024, after the market close on Tuesday, May 14, 2024. A conference call to discuss the fiscal second quarter 2024 financial results will be held at 4:30 p.m. Eastern Time / 1:30 p.m. Pacific Time. Conference call details: Date: May 14, 2024Time: 4:30 p.m. Easter...

 PRESS RELEASE

Karat Packaging to Report 2024 First Quarter Financial Results and Hos...

Karat Packaging to Report 2024 First Quarter Financial Results and Host Conference Call on Thursday, May 9, 2024 CHINO, Calif., April 25, 2024 (GLOBE NEWSWIRE) -- Karat Packaging Inc. (“Karat” or the “Company”) (Nasdaq: KRT), a specialty distributor and manufacturer of environmentally friendly, disposable foodservice products and related items, today announced it will release its 2024 first quarter financial results after market close on Thursday, May 9, 2024. The Company will host an investor conference call on the same day.    Call Date: Thursday, May 9, 2024 Time: 2:00 p.m. PT/5:00 ...

 PRESS RELEASE

BioStem Technologies to Present at the 2024 Planet MicroCap Showcase

BioStem Technologies to Present at the 2024 Planet MicroCap Showcase BioStem CEO, Jason Matuszewski, will present on Wednesday, May 1, 2024 at 11.30 am PST POMPANO BEACH, Fla., April 25, 2024 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental derived biologics for advanced wound care, today announced that it will present at the Planet MicroCap Showcase: VEGAS 2024 held at the Paris Hotel & Casino, in Las Vegas, NV., from April 30 - May 2 2024. BioStem’s Chie...

 PRESS RELEASE

DZS Appoints Scott St. John as Chief Customer Officer

DZS Appoints Scott St. John as Chief Customer Officer Former ADVA Chief Sales Officer to lead global sales, drive revenue growth DALLAS, April 25, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: DZSI), a global leader of broadband networking and AI-driven cloud software solutions, today announced it has appointed Scott St. John as Chief Customer Officer, reporting directly to CEO Charlie Vogt. Mr. St. John will be responsible for leading global sales for DZS and will be focused on driving accelerated revenue growth across the Americas and Europe, Middle East and Africa (EMEA) and Australia/New Zeal...

 PRESS RELEASE

Sportradar Appoints Craig Felenstein as Chief Financial Officer

Sportradar Appoints Craig Felenstein as Chief Financial Officer ST. GALLEN, Switzerland, April 25, 2024 (GLOBE NEWSWIRE) -- Sportradar Group AG (NASDAQ: SRAD)(“Sportradar” or the “Company”) today announced that Craig Felenstein has been named Chief Financial Officer of the Company, effective June 1, 2024. Felenstein joins the Company from Lindblad Expeditions (NASDAQ: LIND) where he most recently served as Chief Financial Officer. He will report directly to Sportradar Chief Executive Officer Carsten Koerl. Felenstein brings nearly 30 years of senior finance and operating experience for U...

 PRESS RELEASE

FibroBiologics Plans to Collaborate with Charles River to Manufacture ...

FibroBiologics Plans to Collaborate with Charles River to Manufacture Fibroblast-based Spheroids Next-generation cell therapies to target chronic diseases HOUSTON, April 25, 2024 (GLOBE NEWSWIRE) -- FibroBiologics, Inc., (Nasdaq: FBLG) ("FibroBiologics") and Charles River Laboratories (“Charles River”), a highly respected, global provider of drug discovery, development, and manufacturing solutions, today announced the signing of a letter of intent allowing for the transfer, testing and validation of FibroBiologics’ technology. This agreement comes ahead of entering into an anticipated m...

 PRESS RELEASE

Zscaler Introduces First of Its Kind Digital Experience Monitoring Cop...

Zscaler Introduces First of Its Kind Digital Experience Monitoring Copilot to Enable IT Support and Operations with AI Zscaler Digital Experience (ZDX) Copilot effortlessly unlocks network, device, and application performance insights in real-time to help quickly resolve issues impacting end users SAN JOSE, Calif., April 25, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: ZS), the leader in cloud security, today announced groundbreaking innovations - ZDX Copilot, Hosted Monitoring, and Data Explorer - to its Zscaler Digital Experience™ (ZDX™) service. The new ZDX Copilot, an AI assistant, instantly ...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch